Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HEMOPHILIA B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01386528
What this trial is testing

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 13
Not applicableStudy completedNCT00703911
What this trial is testing

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 102
Not applicableEnded earlyNCT04628871
What this trial is testing

Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX

Who this might be right for
Hemophilia BMucopolysaccharidosis IMucopolysaccharidosis II
Sangamo Therapeutics 13
Not applicableUnknownNCT02502409
What this trial is testing

Natural History Study of Factor IX Treatment and Complications

Who this might be right for
Factor IX Deficiency
Skane University Hospital 550
Testing effectiveness (Phase 2)Study completedNCT00004801
What this trial is testing

Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency

Who this might be right for
Hemophilia BFactor IX Deficiency
National Center for Research Resources (NCRR) 3
Not applicableStudy completedNCT01029808
What this trial is testing

Bleeding Symptoms of Carriers of Hemophilia A and B

Who this might be right for
Hemophilia
Sahlgrenska University Hospital 126
Post-approval studies (Phase 4)Looking for participantsNCT04647227
What this trial is testing

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
American Thrombosis and Hemostasis Network 55
Large-scale testing (Phase 3)Looking for participantsNCT05145127
What this trial is testing

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Pfizer 245
Not applicableStudy completedNCT03623295
What this trial is testing

The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B

Who this might be right for
Hemophilia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 304
Not applicableUnknownNCT02938156
What this trial is testing

UK - EHL Outcomes Registry

Who this might be right for
Hemophilia AHemophilia B
Royal Free Hospital NHS Foundation Trust 500
Not applicableStudy completedNCT00853086
What this trial is testing

Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 139
Not applicableStudy completedNCT04055051
What this trial is testing

ATHN 11: Liver Transplantation Outcomes Study

Who this might be right for
Hemophilia A and BLiver Transplantation
American Thrombosis and Hemostasis Network 86
Large-scale testing (Phase 3)Study completedNCT02448680
What this trial is testing

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa

Who this might be right for
Hemophilia A With InhibitorsHemophilia B With Inhibitors
Laboratoire français de Fractionnement et de Biotechnologies 25
Early research (Phase 1)Study completedNCT01272206
What this trial is testing

Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 12
Testing effectiveness (Phase 2)Study completedNCT03995784
What this trial is testing

Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Catalyst Biosciences 6
Testing effectiveness (Phase 2)Study completedNCT02484092
What this trial is testing

A Gene Therapy Study for Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 15
Early research (Phase 1)Study completedNCT04747964
What this trial is testing

A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 16
Testing effectiveness (Phase 2)UnknownNCT04114643
What this trial is testing

Factor Replacement in Surgery

Who this might be right for
Bleeding in Cardiac Surgery
University Health Network, Toronto 103
Post-approval studies (Phase 4)Study completedNCT01748201
What this trial is testing

Viscosupplementation in Patients With Hemophilic Arthropathy

Who this might be right for
OsteoarthritisHemarthrosisHemophilia A+1 more
University of Sao Paulo General Hospital 13
Large-scale testing (Phase 3)Study completedNCT02141074
What this trial is testing

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 54
Next Page